导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 14.14% | 238/326 |
| 近一周 | 2.06% | 11/355 |
| 近一月 | 2.30% | 28/354 |
| 近一季 | 11.70% | 16/350 |
| 近半年 | 12.71% | 95/341 |
| 近一年 | 12.01% | 209/325 |
| 近两年 | 16.72% | 232/270 |
| 近三年 | 15.90% | 161/191 |
| 成立以来 | 143.64% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
5.57% 137/341 |
-5.12% 326/349 |
3.13% 327/355 |
- - |
| 2024 | 0.16% 228/330 |
5.19% 134/280 |
-0.30% 200/310 |
6.58% 142/319 |
-10.40% 295/330 |
| 2023 | 2.40% 115/276 |
-1.95% 164/205 |
2.65% 110/230 |
-2.38% 32/262 |
4.23% 142/276 |
| 2022 | -2.65% 20/202 |
-1.80% 16/153 |
-5.27% 74/164 |
-6.28% 83/189 |
11.66% 91/202 |
| 2021 | 18.22% 45/151 |
0.60% 186/312 |
7.53% 103/328 |
0.03% 96/358 |
9.24% 35/151 |
| 2020 | 9.89% 41/104 |
-10.95% 135/280 |
11.84% 156/295 |
4.04% 107/299 |
6.06% 193/305 |
| 2019 | 20.81% 43/89 |
7.73% 160/258 |
1.15% 143/268 |
-1.00% 173/253 |
11.99% 38/266 |
| 2018 | 1.25% 14/80 |
- - |
- - |
- - |
-8.85% 105/241 |
| 2017 | 18.28% 32/69 |
- - |
- - |
- - |
- - |
| 2016 | -7.48% 44/59 |
- - |
- - |
- - |
- - |
| 2015 | 5.36% 14/49 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 易方达标普生物科技美元汇A | 0.2432 | 29.46% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 汇安行业龙头混合A | 2.4323 | 22.37% |
| 华商致远回报混合A | 1.6762 | 21.58% |
| 广发生物科技指数美元(QDII)C | 0.2047 | 18.46% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇 | 1.3424 | 17.84% |
| 华夏上证科创板半导体材料设备主题ETF联接C | 1.2373 | 17.83% |
| 宝盈国家安全沪港深股票C | 2.1469 | 17.42% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币A | 1.3726 | 17.14% |
| 广发上海金ETF | 9.7032 | 16.81% |
| 广发全球医疗保健美元现汇(QDII)A VS. () |